All Stories

  1. Efficacy and safety of vorapaxar for secondary prevention in low body weight in patients with atherosclerosis: analyses from the TRA 2°P-TIMI 50 Trial

    Article • European Heart Journal Acute Cardiovascular Care, October 2019, SAGE Publications

    David Morrow

  2. Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial

    Article • European Heart Journal, May 2019, Oxford University Press (OUP)

    David Morrow

  3. Vorapaxar for secondary prevention in the elderly with peripheral artery disease: Insights from the TRA 2°P-TIMI 50 trial

    Article • Vascular Medicine, March 2019, SAGE Publications

    David Morrow

  4. Prognostic role of GDF-15 across the spectrum of clinical risk in patients with NSTE-ACS

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), February 2019, De Gruyter

    David Morrow

  5. Characteristics of patients in a contemporary advanced cardiac intensive care unit

    Article • European Heart Journal Acute Cardiovascular Care, July 2018, SAGE Publications

    David Morrow

  6. Cardiovascular Disease: Impact of Biomarkers, Proteomics, and Genomics

    Article • Clinical Chemistry, December 2016, AACC

    David Morrow

  7. High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial

    Article • Clinical Chemistry, November 2016, AACC

    Petr Jarolím, Keith Fox, Dr Eugene Braunwald, David Morrow

  8. Vorapaxar in patients with coronary artery bypass grafting: Findings from the TRA 2°P-TIMI 50 trial

    Article • European Heart Journal Acute Cardiovascular Care, September 2016, SAGE Publications

    David Morrow

  9. In Search of the 1-Hour Rule-Out for Acute Myocardial Infarction

    Article • Clinical Chemistry, October 2015, AACC

    David Morrow

  10. Outcomes in patients undergoing percutaneous ventricular assist device implantation for cardiogenic shock

    Article • European Heart Journal Acute Cardiovascular Care, April 2015, SAGE Publications

    David Morrow

  11. Preanalytical Considerations in the Design of Clinical Trials and Epidemiological Studies

    Article • Clinical Chemistry, April 2015, AACC

    Dr Christina Ellervik, David Morrow